Research News and Research

RSS

Mathematical model predicts progress of tumors from early stages to metastasis

Researchers from the University of Miami (UM) and the University of Heidelberg in Germany have developed a mathematical model to understand and predict the progress of a tumor, from its early stages to metastasis, in hopes of creating highly personalized treatment strategies for patients who have cancer. The findings are published in Nature's new online journal Scientific Reports.

1 Aug 2011

Viewpoints on debt-ceiling debate center on Medicare

For weeks, ever since House Republicans said they would not raise the nation's debt ceiling without huge spending cuts, Democrats have held out for a few basic principles.

1 Aug 2011

Disparities persist despite insurance

A pair of studies highlights how health disparities continue to take shape and unravels some of the factors that are involved in differences in health outcomes.

1 Aug 2011

Bipartisan support for NIH funding eroding

Voting to boost funding for the National Institutes Health has long been a source of pride for Democrats and Republicans alike. But the drive to shrink the federal government is now eroding bipartisan backing for an agency that supports scientific research to prevent illnesses such as strokes, heart attacks and cancer.

1 Aug 2011

Auxilium second quarter net loss decreases to $5.1 million

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced financial results and operational highlights for the quarter ended June 30, 2011. For the second quarter of 2011, Auxilium reported net revenues of $65.9 million compared to net revenues of $50.5 million in the second quarter of 2010.

1 Aug 2011

Medical device review system called into question

An advisory group offered criticism of the Food and Drug Administration's review system for medical devices. But the FDA's reaction appears dismissive.

1 Aug 2011

FDA approves Medtronic's IDE for Advisa DR MRI SureScan pacing system

Medtronic, Inc. today announced U.S. Food and Drug Administration approval for its Investigational Device Exemption (IDE) application and pivotal clinical trial protocol to begin evaluating Advisa DR MRI SureScan pacing system.

From Medtronic 1 Aug 2011

First Edition: August 1, 2011

In today's headlines, the early details regarding how the politics and policies involved of the debt-ceiling deal are taking shape.

1 Aug 2011

Mobile health software effectively helps manage diabetes

An interactive computer software program appears to be effective in helping patients manage their Type 2 diabetes using their mobile phones, according to a new study by University of Maryland School of Medicine researchers.

1 Aug 2011

Positive results from Alnylam's ALN-VSP Phase I trial for liver cancer

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has completed its Phase I study with ALN-VSP, a systemically delivered RNAi therapeutic for the treatment of advanced solid tumors with liver involvement.

1 Aug 2011

Cubist initiates CXA-201 Phase 3 trial in complicated urinary tract infections

Cubist Pharmaceuticals, Inc. today announced the initiation of a pivotal Phase 3 trial of CXA-201 in patients with complicated urinary tract infections.

1 Aug 2011

PathoGenetiX receives $4.0 million in first close of Series B financing

PathoGenetiX Inc., today announced that the Company has received $4.0 million in the first closing of its Series B financing.

1 Aug 2011

Nature Biotechnology publishes BGI, GT Life Sciences' study on CHO K1 genome

BGI, the world's largest genomics organization, and GT Life Sciences, Inc., a privately held biotechnology company that utilizes a proven metabolic modeling and experimental platform to drive the discovery and design of new products and processes for the life sciences field, announced today that their collaborative study on the genomic sequence of the Chinese hamster ovary (CHO) K1 cell line was published July 31, 2011 online in Nature Biotechnology.

1 Aug 2011

Artificial nanoparticles have direct effect on heart rate and rhythm

Artificial nanoparticles are becoming increasingly pervasive in modern life. However, their influence on our health and the mechanisms by which they affect the human body remain largely shrouded in mystery.

1 Aug 2011

Affymetrix to commercialize four Axiom genotyping arrays for the major populations

Affymetrix, Inc. today announced plans to commercialize four Axiom population-optimized arrays used to analyze 100,000 samples collected from volunteers in one of the nation's largest and most diverse genomics projects funded by the National Institutes of Health.

1 Aug 2011